Intermittent Claudication Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark
Conditions: Intermittent Claudication Interventions: Other: Supervised exercise therapy Sponsors: Slagelse Hospital; Region Zealand; Vordingborg Municipality; Kalundborg municipality; K øge Municipality; Næstved municipality; Solrød Municipality Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease
Conditions: Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions; Moderate or Severe Claudication (Rutherford Category 2 or 3); Critical Limb Ischemia (Rutherford Category 4 or 5) Interventions: Device: Implantation of Eluvia stent Sponsors: Yonsei University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Heat Therapy for Peripheral Arterial Disease (HEATPAD)
Conditions: Peripheral Arterial Disease; Intermittent Claudication; Critical Limb Ischemia Interventions: Device: AirGlove Sponsors: Norfolk and Norwich University Hospitals NHS Foundation Trust; GreenCross Medico Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Neurostimulation in Intermittent Claudication
Conditions: Claudication Interventions: Device: Neurostimulating device Sponsors: The Leeds Teaching Hospitals NHS Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
Conditions: Intermittent Claudication Interventions: Drug: Cilostazol Tablet 100 mg; Drug: PMR Tablet 145 mg Sponsors: Genovate Biotechnology Co., Ltd., Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in Intermittent Claudication
Conditions: Peripheral Artery Disease; Intermittent Claudication Interventions: Behavioral: Walking exercise behaviour change intervention + TENS Sponsors: Glasgow Caledonian University; King ' s College London; St George ' s, University of London; University of Glasgow; NHS Lanarkshire Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Interventions: Procedure: FRAMED Infrainguinal Venous Bypass; Procedure: Conventional Autologous Bypass Sponsors: Paracelsus Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Bypass Complication; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Intervention: Procedure: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Bypass Complication; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Interventions: Procedure: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
Conditions: Arterial Occlusive Diseases; Intermittent Claudication Interventions: Drug: Sarpogrelate SR; Drug: Sarpogrelate Sponsor: Yuhan Corporation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials